X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | AMLX | Frates James M | CFO | S - Sale | $3.47 | -10,896 | 317,519 | -3% | -$37,806 | ||||||
2025-03-31 | AMLX | Bedrosian Camille L | Chief Medical Officer | S - Sale | $3.47 | -12,425 | 194,375 | -6% | -$43,082 | ||||||
2025-03-31 | AMLX | Mazzariello Gina | GC | S - Sale | $3.48 | -9,192 | 187,969 | -5% | -$31,954 | ||||||
2025-03-31 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $3.47 | -21,490 | 3,355,280 | -1% | -$74,482 | ||||||
2025-03-31 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $3.46 | -21,490 | 3,355,276 | -1% | -$74,454 | ||||||
2025-03-20 | AMLX | Zeiher Bernhardt G | Dir | P - Purchase | $3.70 | +10,000 | 10,000 | New | +$37,005 | ||||||
2025-03-03 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $3.15 | -4,595 | 3,196,648 | 0% | -$14,483 | ||||||
2025-03-03 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $3.17 | -4,595 | 3,196,652 | 0% | -$14,549 | ||||||
2025-03-03 | AMLX | Mazzariello Gina | GC | S - Sale | $3.12 | -1,611 | 133,310 | -1% | -$5,022 | ||||||
2025-02-24 | AMLX | Mazzariello Gina | GC | S - Sale | $3.15 | -4,169 | 134,921 | -3% | -$13,145 | ||||||
2025-02-03 | AMLX | Mazzariello Gina | GC | S - Sale | $3.49 | -3,678 | 139,090 | -3% | -$12,839 | ||||||
2025-02-03 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $3.47 | -11,851 | 3,201,247 | 0% | -$41,108 | ||||||
2025-02-03 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $3.47 | -11,855 | 3,164,933 | 0% | -$41,104 | ||||||
2025-01-06 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $4.04 | -7,471 | 3,176,788 | 0% | -$30,202 | ||||||
2025-01-06 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $4.05 | -7,471 | 3,213,098 | 0% | -$30,232 | ||||||
2024-12-02 | AMLX | Bedrosian Camille L | Chief Medical Officer | S - Sale | $5.54 | -5,421 | 138,380 | -4% | -$30,007 | ||||||
2024-09-30 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $3.20 | -18,589 | 3,120,569 | -1% | -$59,429 | ||||||
2024-09-30 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $3.20 | -18,589 | 3,220,569 | -1% | -$59,414 | ||||||
2024-09-30 | AMLX | Bedrosian Camille L | Chief Medical Officer | S - Sale | $3.20 | -11,442 | 143,801 | -7% | -$36,559 | ||||||
2024-09-30 | AMLX | Mazzariello Gina | GC | S - Sale | $3.20 | -8,709 | 142,768 | -6% | -$27,840 | ||||||
2024-09-12 | AMLX | Frates James M | CFO | P - Purchase | $2.53 | +40,000 | 259,995 | +18% | +$101,368 | ||||||
2024-09-05 | AMLX | Firestone Karen | Dir | P - Purchase | $2.13 | +50,000 | 55,000 | >999% | +$106,590 | ||||||
2024-09-03 | AMLX | Milne George M Jr | Dir | P - Purchase | $2.20 | +100,000 | 858,571 | +13% | +$219,800 | ||||||
| M | 2024-05-14 | AMLX | Quimi Daphne | Dir | P - Purchase | $1.89 | +5,000 | 5,000 | New | +$9,436 | |||||
2024-05-15 | AMLX | Mazzariello Gina | GC | S - Sale | $1.88 | -10,455 | 151,477 | -6% | -$19,654 | ||||||
2024-03-05 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $18.73 | -4,135 | 3,023,002 | 0% | -$77,440 | ||||||
2024-03-05 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $18.73 | -4,135 | 2,959,308 | 0% | -$77,440 | ||||||
2024-03-05 | AMLX | Frates James M | CFO | S - Sale | $18.73 | -1,792 | 161,315 | -1% | -$33,560 | ||||||
2024-03-05 | AMLX | Mazzariello Gina | GC | S - Sale | $18.73 | -1,540 | 81,372 | -2% | -$28,841 | ||||||
2024-02-23 | AMLX | Mazzariello Gina | GC | S - Sale | $18.76 | -2,838 | 46,245 | -6% | -$53,231 | ||||||
2024-01-09 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $16.33 | -5,841 | 2,836,776 | 0% | -$95,372 | ||||||
2024-01-09 | AMLX | Frates James M | CFO | S - Sale | $16.33 | -2,716 | 123,107 | -2% | -$44,347 | ||||||
2024-01-09 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $16.33 | -5,841 | 2,900,470 | 0% | -$95,372 | ||||||
2024-01-09 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale | $16.33 | -2,812 | 205,605 | -1% | -$45,915 | ||||||
2023-12-15 | AMLX | Firestone Karen | Dir | P - Purchase | $14.97 | +4,000 | 5,000 | +400% | +$59,880 | ||||||
2023-08-15 | AMLX | Mazzariello Gina | GC | S - Sale | $20.88 | -6,164 | 49,083 | -11% | -$128,686 | ||||||
| D | 2023-05-16 | AMLX | Frates James M | CFO | S - Sale+OE | $26.94 | -32,500 | 75,158 | -30% | -$875,451 | |||||
| D | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $29.03 | -11,965 | 208,417 | -5% | -$347,358 | |||||
| D | 2023-04-17 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $30.54 | -49,579 | 208,417 | -19% | -$1,513,942 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |